Status:
COMPLETED
Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia
Lead Sponsor:
Eli Lilly and Company
Conditions:
Schizophrenia
Eligibility:
All Genders
18-55 years
Phase:
PHASE4
Brief Summary
The purposes of this study are to assess similarities and differences in the efficacy (how well the drug works), safety, and side effects of olanzapine and aripiprazole in patients with schizophrenia,...
Eligibility Criteria
Inclusion
- Patients must have schizophrenia, schizoaffective disorder, or schizophreniform disorder
- Patients must be agitated
- Patients must display psychotic symptoms
- Patients must be inpatients who are expected to stay in the hospital for at least 5 days
- Patients must be 18 to 55 years of age
Exclusion
- Patients may not be hospitalized for greater than 72 hours prior to study start
- Patients may not have received more than one dose of olanzapine or aripiprazole within 72 hours prior to study start
- Patients may not be actively suicidal
- Patients may not be diagnosed with substance-induced psychosis or substance dependence
- Patients may not have acute, serious, or unstable medical conditions
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
End Date :
August 1 2006
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00103571
Start Date
July 1 2004
End Date
August 1 2006
Last Update
November 6 2007
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. test
Saint Charles, Missouri, United States, 63301
2
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. test
Beachwood, Ohio, United States, 44122
3
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. test
Canton, Ohio, United States, 44708
4
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. test
Memphis, Tennessee, United States, 38117